investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Genomic Disruption in High-Grade Serous Ovarian Carcinomas: Steady State or Continuous Drift?
Sohrab Shah
0 Collaborator(s)
Funding source
Canadian Institutes of Health Research (CIHR)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
No posts
Related projects
Susan J Ramus
Identifying Prognostic Markers and Therapeutic Targets for Serous Ovarian Cancer
Ovary
Pathology
Kunle O Odunsi
mTOR inhibition for generating memory T cells to enhance ovarian tumor immunity
Ovary
Pathology
Mary Anne Rossing
Epidemiologic Factors and Survival by Molecular Subtypes of Ovarian Cancer
Ovary
Pathology
Linda S Cook
Mitochondrial DNA and Ovarian Cancer Risk and Survival
Ovary
Pathology
Celeste Leigh Pearce
Mechanisms of Prevention of Ovarian Cancer by Oral Contraceptives
Ovary
Pathology
Charles D Blanke
SWOG Network Group Operations Center of the NCTN
Ovary
Janet E Dancey
NCIC Clinical Trials Group - Canadian Collaborating Clinical Trials Network
Ovary
Meir Stampfer
Dietary and Hormonal Determinants of Cancer in Women
Ovary
Thomas Kislinger
A Novel Biomarker Discovery Strategy Combining Primary Tumour Xenograft Models and Glyco-Capture of Secreted Proteins
Ovary